Baskhanbio Pharma Inc. (XKON:354390)
3,600.00
-140.00 (-3.74%)
At close: Aug 21, 2026
-26.15% (1Y)
| Market Cap | 25.27B -26.2% |
| Revenue | n/a |
| Net Income | n/a |
| EPS | n/a |
| Shares Out | 7.02M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 281 |
| Open | 3,505.00 |
| Previous Close | 3,740.00 |
| Day's Range | 3,355.00 - 3,600.00 |
| 52-Week Range | 2,860.00 - 6,090.00 |
| Beta | 0.33 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | n/a |